Vivani Medical, Inc. (VANI) stock
VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.05+0.03 (+2.94%)
Close on Nov 17, 2026Market cap $94.71MP/E –Yield –
Vivani Medical total assets
Total assets on the balance sheet at the end of each period.
Vivani Medical's total assets was $41.64M at Jun 30, 2026. For fiscal 2025 it was $39.39M, down 5.2% from the year before. Over ten years it grew 3.4% a year on average. The highest annual figure on record is $51.13M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.39M | -5.2% |
| FY2024 | Dec 31, 2024 | $41.56M | -9.2% |
| FY2023 | Dec 31, 2023 | $45.80M | -10.4% |
| FY2022 | Dec 31, 2022 | $51.13M | +837.6% |
| FY2021 | Dec 31, 2021 | $5.45M | +22.3% |
| FY2020 | Dec 31, 2020 | $4.46M | -73.1% |
| FY2019 | Dec 31, 2019 | $16.60M | +55.4% |
| FY2018 | Dec 31, 2018 | $10.68M | -26.3% |
| FY2017 | Dec 31, 2017 | $14.50M | -13.8% |
| FY2016 | Dec 31, 2016 | $16.81M | -40.5% |
| FY2015 | Dec 31, 2015 | $28.25M | -34.4% |
| FY2014 | Dec 31, 2014 | $43.07M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $41.64M | +44.1% |
| Q1 FY2026 | Mar 31, 2026 | $42.35M | +19.5% |
| Q4 FY2025 | Dec 31, 2025 | $39.39M | -5.2% |
| Q3 FY2025 | Sep 30, 2025 | $25.05M | -41.6% |
| Q2 FY2025 | Jun 30, 2025 | $28.91M | -40.1% |
| Q1 FY2025 | Mar 31, 2025 | $35.45M | -34.1% |
| Q4 FY2024 | Dec 31, 2024 | $41.56M | -9.2% |
| Q3 FY2024 | Sep 30, 2024 | $42.90M | -19.5% |
| Q2 FY2024 | Jun 30, 2024 | $48.22M | -19.1% |
| Q1 FY2024 | Mar 31, 2024 | $53.79M | +20.7% |
| Q4 FY2023 | Dec 31, 2023 | $45.80M | -10.4% |
| Q3 FY2023 | Sep 30, 2023 | $53.32M | -6.5% |
| Q2 FY2023 | Jun 30, 2023 | $59.61M | -9.2% |
| Q1 FY2023 | Mar 31, 2023 | $44.58M | -35.0% |
| Q4 FY2022 | Dec 31, 2022 | $51.13M | +837.6% |
| Q3 FY2022 | Sep 30, 2022 | $57.02M | -22.6% |
| Q2 FY2022 | Jun 30, 2022 | $65.65M | -13.5% |
| Q1 FY2022 | Mar 31, 2022 | $68.54M | +143.5% |
| Q4 FY2021 | Dec 31, 2021 | $5.45M | +22.3% |
| Q3 FY2021 | Sep 30, 2021 | $73.63M | +1990.6% |
| Q2 FY2021 | Jun 30, 2021 | $75.92M | +1479.9% |
| Q1 FY2021 | Mar 31, 2021 | $28.15M | +620.9% |
| Q4 FY2020 | Dec 31, 2020 | $4.46M | -73.1% |
| Q3 FY2020 | Sep 30, 2020 | $3.52M | -85.3% |
| Q2 FY2020 | Jun 30, 2020 | $4.81M | -84.8% |
| Q1 FY2020 | Mar 31, 2020 | $3.90M | -89.9% |
| Q4 FY2019 | Dec 31, 2019 | $16.60M | +55.4% |
| Q3 FY2019 | Sep 30, 2019 | $23.90M | +109.3% |
| Q2 FY2019 | Jun 30, 2019 | $31.52M | +131.5% |
| Q1 FY2019 | Mar 31, 2019 | $38.55M | +270.4% |
| Q4 FY2018 | Dec 31, 2018 | $10.68M | -26.3% |
| Q3 FY2018 | Sep 30, 2018 | $11.42M | -40.1% |
| Q2 FY2018 | Jun 30, 2018 | $13.62M | -43.9% |
| Q1 FY2018 | Mar 31, 2018 | $10.41M | -65.5% |
| Q4 FY2017 | Dec 31, 2017 | $14.50M | -13.8% |
| Q3 FY2017 | Sep 30, 2017 | $19.08M | -27.4% |
| Q2 FY2017 | Jun 30, 2017 | $24.27M | – |
| Q1 FY2017 | Mar 31, 2017 | $30.12M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.81M | – |
| Q3 FY2016 | Sep 30, 2016 | $26.27M | – |
See a number that looks wrong?